Kentucky Cannabis
Market Intelligence Report

Kentucky's medical cannabis program, enacted via Senate Bill 47 in March 2023 and effective January 1, 2025, made its first legal retail sale on December 20, 2025, at The Post Dispensary in Beaver Dam — which promptly sold out of its limited stock within days. The program had already accumulated more than 23,000 registered patients before broad dispensary access began; by May 2026, over 17,000 patients had received doctor certifications and more than 11,000 had been issued formal patient ID cards.

The supply side has lagged patient demand: of 48 dispensary licenses awarded from nearly 5,000 applications, only 12 were open and operating as of May 11, 2026. Governor Andy Beshear has publicly said he is "not satisfied" with the pace of the rollout, while expressing confidence the pace will "pick up significantly" through the remainder of 2026. An MJBiz Factbook projection estimates the program could generate $126 million in sales in 2026, its first full calendar year of operation.

Kentucky's population of roughly 4.5 million provides a substantial addressable patient base, with household income somewhat below the national median. (Official, Census ACS 2024)

Kentucky's medical cannabis program is regulated by the Office of Medical Cannabis under the Cabinet for Health and Family Services. The state awarded 48 dispensary licenses from a pool of nearly 5,000 applicants, alongside a tiered cultivator licensing structure (Tier I at up to 2,500 square feet through Tier IV at up to 50,000 square feet) and processor licensing, with the first processor license approved in January 2026. Dispensary applicants pay a $5,000 nonrefundable application fee, a $30,000 initial licensing fee, and a $15,000 annual renewal fee.

Kentucky does not operate a dedicated cannabis tax-incentive or grant program; its defining cost-side feature is the dispensary licensing fee structure itself ($5,000 application, $30,000 initial license, $15,000 annual renewal).

Kentucky's cannabis supply chain is the newest in this report set, having produced its first legal sale only in December 2025. The first dispensary sold out of inventory within days, and as of January 2026 the state had approved only its first processor license — meaning cultivation, processing, and dispensing capacity are all still scaling up simultaneously. Industry coverage has consistently flagged "supply woes" as the primary constraint on the program's early rollout, more so than patient demand, which has run well ahead of available product.

Patient registration has consistently outpaced the program's ability to issue ID cards and provide dispensary access, the clearest sign of strong underlying demand running ahead of program infrastructure. (Official)

Kentucky's first operating dispensaries are concentrated in a small number of communities, including Beaver Dam, with the network of 12 operating locations (out of 48 licensed) expected to expand across the state through 2026. The Office of Medical Cannabis does not yet publish a county-by-county sales breakdown for this newly launched program. (Not Available — county-level sales breakdown.)

Kentucky's dispensary licensing fee structure is publicly documented and consistent across all 48 awarded licenses.

Vendor demand signal tracks which product and service categories Kentucky's newly opening dispensaries and cultivators are actively sourcing this quarter.

Kentucky has not enacted a cannabis-specific excise tax, and the most current, authoritative guidance indicates medical cannabis sold to registered patients is exempt from the state's general sales tax — though some secondary tax-guide sources report conflicting information on this point, so this should be confirmed against current Office of Medical Cannabis guidance for any transaction-level decision. The state's primary direct cannabis-related revenue currently comes from dispensary, cultivator, and processor licensing fees rather than point-of-sale taxation.

Kentucky borders seven states with a wide mix of cannabis policy, from established adult-use markets to full prohibition.

Kentucky does not yet publish a consolidated statewide cannabis-industry employment figure, given the program's December 2025 launch. With only 12 of 48 licensed dispensaries operating and cultivation/processing capacity still scaling, current direct employment is likely modest but growing quickly. (Not Available.)

Kentucky's medical cannabis program does not include a dedicated statewide social equity license track; licenses were awarded through a competitive application process from the nearly 5,000 applications received. (Official.)

Kentucky does not publish an official illicit cannabis market size estimate. With cannabis remaining illegal for non-patient adult use, and the licensed medical supply chain still ramping up against strong patient demand (illustrated by the state's first dispensary selling out within days), an unregulated market likely persists alongside the new medical program, though no official dollar figure quantifies this. (Not Available.)

This report blends official Kentucky Office of Medical Cannabis licensing and patient data, industry sales projections (clearly labeled), state legislative records, and federal demographic sources. Tax-treatment guidance showed some inconsistency across secondary sources and is flagged accordingly.

This report compiles data from the Kentucky Office of Medical Cannabis, state government officials, industry trade press, federal demographic sources, and reputable cannabis policy media.